BIO CEO: About Company Presentations
The 14th Annual BIO CEO & Investor Conference assembles a select group of established public biotech companies, as well as top public and private equity investors and members of the sell-side investment community, to explore the current investment landscape and opportunities in life sciences. In addition to plenary sessions and panel discussions on timely business topics and key therapeutic areas, the conference features presentations by over 130 leading biotechnology and pharmaceutical companies, as well as a number of nonprofit and venture philanthropy organizations.
If you've been invited to present, confirm your presentation early to guarantee your spot! We are also accepting applications, - submit one today!
Presenting companies are hand-selected for the event, and consist of a selection of mid- to large-cap established public companies from around the globe, who typically have a clinical stage program centered around therapeutics, molecular diagnostics, or a platform technology, as well as an upcoming clinical, regulatory, or corporate catalyst. The typical audience for a company presentation features public and private equity investors, as well as industry analysts, investment bankers and senior biotechnology executives.
Click here to Apply to Present!
To see a current list of the 2012 presenting companies, please click here. For questions regarding company presentations, please visit the Presenter Resource Center, or contact Sondra Behan.
